MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the
issuance of common stock,...
$123,600K
Proceeds from the
issuance of common stock...
$42,785K
Proceeds from the
exercise of warrants
$5,510K
Proceeds from the
issuance of common stock...
$1,922K
Proceeds from the
issuance of common stock...
$725K
Proceeds from the
exercise of stock options
$125K
Net cash provided by
financing activities
$174,667K
Net increase in cash
and cash...
$20,106K
Canceled cashflow
$154,561K
Proceeds from maturities
of marketable...
$116,432K
Stock-based compensation
$4,677K
Other accrued
expenses
$887K
Non-cash rent expense
$851K
Accounts payable
$586K
Depreciation and
amortization
$129K
Accrued research and
development expenses
$114K
Net cash (used in)
provided by investing...
-$113,468K
Net cash used in
operating activities
-$41,093K
Canceled cashflow
$116,432K
Canceled cashflow
$7,244K
Collaboration revenue from a
related party
$72,303K
Interest and other
income, net
$5,996K
Purchases of marketable
securities
$229,834K
Deferred revenue from a
related party
-$36,096K
Net loss
-$6,122K
Purchases of property and
equipment
$66K
Canceled cashflow
$78,299K
Net accretion of
investments in marketable...
$2,346K
Prepaid expenses and
other current assets
$2,045K
Accounts receivable from
collaboration
$974K
Operating lease
liabilities
-$751K
Realized gain on
investments in marketable...
$3K
Total research and
development
$64,813K
General and
administrative
$19,608K
Back
Back
Cash Flow
source: myfinsight.com
ASSEMBLY BIOSCIENCES, INC. (ASMB)
ASSEMBLY BIOSCIENCES, INC. (ASMB)